Calidi Biotherapeutics (CLDI) Other Non Operating Income (2022 - 2025)
Calidi Biotherapeutics' quarterly Other Non Operating Income came in at $117000.0 in Q4 2025, up 1362.5% year-on-year from $8000.0 in Q4 2024, and up 550.0% quarter-over-quarter from $18000.0 in Q3 2025.
Calidi Biotherapeutics has reported Other Non Operating Income for 4 years, with the latest figure at $117000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non Operating Income rose 1362.5% year-over-year to $117000.0; the trailing twelve-month figure through Dec 2025 stood at $103000.0 (up 1044.44% YoY), and the FY2025 full-year result was $103000.0, up 1044.44% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $117000.0, up from $18000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $117000.0 in Q4 2025, with the low at -$22000.0 in Q4 2023.
- Average Other Non Operating Income over 4 years is $3714.3, with a median of -$6500.0 recorded in 2023.
- Peak annual rise in Other Non Operating Income reached 1362.5% in 2025, while the deepest fall reached 320.0% in 2025.
- Tracing CLDI's Other Non Operating Income over 4 years: stood at -$13000.0 in 2022, then tumbled by 69.23% to -$22000.0 in 2023, then jumped by 136.36% to $8000.0 in 2024, then surged by 1362.5% to $117000.0 in 2025.
- The last three Other Non Operating Income figures came in at $117000.0 (Q4 2025), $18000.0 (Q3 2025), and -$22000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 117,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | -17,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -16,000.00 |
| Mar 31, 2023 | -5,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | 4,000.00 |